Our Experience

For over 10 years we have been participating in large epidemiological and intervention drug studies whether they’ve been cross-sectionnal or prospective. The table below shows the importance of these studies gathering more than 25 000 patients in 50 countries representing more than 600 centers.

During these clinical trials we have handled site set-up, investigator training, documents drawing, operations follow-up and central reading of data collected from the centers.

Our experience is unique and IMT is the only corelab worldwide developping and commercializing dedicated tools to carry out medical imaging studies.

StudyCountries
(number)
Centers
(number)
Patients
(number)
Type of StudyModalitiesParametersContinent
Parc12506500EpidemiologicalCross-SectionalIMT/DEurope
N°2155700ObservationalCross-SectionalIMT/PlaqueEurope
PARCAALA30983000EpidemiologicalCross-SectionalIMT/D/PlaqueEurope, Asia, South America, Africa
CARMELA7711200EpidemiologicalCross-SectionalIMT/D/PlaqueSouth America
N°511400InterventionalProspective : 2 yearsIMT/STIFFNESSEurope
N°61580InterventionalProspective : 5 yearsIMT/STIFFNESSEurope
IMMEDIAT42502000ObservationalCross-SectionalIMT/DEurope
N°712002000ObservationalProspective : 2 yearsIMT/D/PlaqueEurope